Pulmatrix Inc (PULM)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Teofilo Raad
Employees:
20
99 HAYDEN AVENUE, SUITE 390, LEXINGTON, MA 02421
(781) 357-2333

Pulmatrix, Inc. discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology. Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis, and in patients with cystic fibrosis, is in Phase 1b clinical trials.

Data derived from most recent annual or quarterly report
Market Cap 7.085 Million Shares Outstanding3.652 Million Avg 30-day Volume 10.496 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.45
Price to Revenue1.4139 Debt to Equity0.0 EBITDA-16.665 Million
Price to Book Value0.4174 Operating Margin-260.0173 Enterprise Value-16.156 Million
Current Ratio7.612 EPS Growth0.352 Quick Ratio7.286
1 Yr BETA 0.4283 52-week High/Low 4.49 / 1.64 Profit Margin-253.2428
Operating Cash Flow Growth-0.3693 Free Cash Flow to Firm (FCFF) TTM -14.725 Million Free Cash Flow to Equity (FCFE) TTM-12.668 Million
Altman Z-Score-12.6174
View SEC Filings from PULM instead.

View recent insider trading info

Pulmatrix Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding PULM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PULM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-30 by SIEGERT MICHELLE
  • 4: filed on 2023-01-30 by HIGGINS MICHAEL J
  • 4: filed on 2023-01-30 by VARADAN ANAND
  • 4: filed on 2023-01-30 by BATYCKY RICHARD P.
  • 3: filed on 2022-04-19 by LUDLUM PETER
  • 4: filed on 2022-03-03 by WASILEWSKI MARGARET
  • 3: filed on 2022-03-03 by WASILEWSKI MARGARET
  • 4: filed on 2022-01-31 by HIGGINS MICHAEL J
  • 4: filed on 2022-01-31 by BATYCKY RICHARD P.
  • 4: filed on 2022-01-31 by CABELL CHRISTOPHER

    • Events (8k)

  • 8-K: filed on 2023-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-07-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-25:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HIGGINS MICHAEL J

    • Director
    		 2,436 2023-01-26 1

    BAZEMORE TODD

    • Director
    		 1,700 2023-01-26 1

    BATYCKY RICHARD P.

    • Director
    		 1,700 2023-01-26 1

    VARADAN ANAND

    • Director
    		 1,700 2023-01-26 1

    RAAD TEOFILO DAVID CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 34,900 2023-01-26 1

    SIEGERT MICHELLE VICE PRESIDENT, FINANCE

    • Officer
    		 9,900 2023-01-26 1

    CABELL CHRISTOPHER

    • Director
    		 1,700 2023-01-26 1

    WASILEWSKI MARGARET CHIEF MEDICAL OFFICER

    • Officer
    		 11,400 2023-01-26 1

    LUDLUM PETER INTERIM CFO

    • Officer
    		 0 2022-04-18 0

    IWICKI MARK T

    • Director
    		 0 2021-01-28 0

    MUNSHI AMIT

    • Director
    		 0 2021-01-28 0

    GILLIS STEVEN

    • Director
    		 No longer subject to file 2020-08-28 0

    MCGUIRE TERRANCE

    • Director
    		 0 2019-05-16 0

    SHERMAN MATTHEW L

    • Director
    		 0 2019-05-16 0

    DUKE WILLIAM E. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-05-16 0

    ROACH JAMES M. CHIEF MEDICAL OFFICER

    • Officer
    		 0 2018-06-05 0

    HAVA DAVID L. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2018-06-05 0

    CLARKE ROBERT W. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2018-06-05 0

    MCGUIRE TERRANCE

    FLINT JONATHAN A

    POLARIS VENTURE MANAGEMENT CO IV LLC

    POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP

    POLARIS VENTURE PARTNERS IV LP

    POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

    POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

    POLARIS VENTURE PARTNERS V, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

    • Director
    • 10% Owner
    		 6,330,235 2018-04-03 0

    GILLIS STEVEN

    ARCH VENTURE FUND VII LP

    ARCH VENTURE PARTNERS VII, L.P.

    ARCH VENTURE PARTNERS VII, LLC

    CRANDELL KEITH

    BYBEE CLINTON

    NELSEN ROBERT

    • Director
    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 4,586,456 2018-04-03 0

    ARCH VENTURE FUND VII LP

    ARCH VENTURE PARTNERS VII, L.P.

    ARCH VENTURE PARTNERS VII, LLC

    CRANDELL KEITH

    BYBEE CLINTON

    NELSEN ROBERT

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2018-04-03 0

    ROCKLAGE SCOTT M

    • Director
    		 0 2016-02-03 0

    GRAVES KURT

    • Director
    		 0 2016-02-03 0

    OCULUS INNOVATIVE SCIENCES, INC.

    • 10% Owner
    		 0 2015-06-16 0

    MAKI DAVID

    • Director
    		 0 2015-06-15 0

    AKAO AKIHISA

    • Director
    		 0 2015-04-30 0

    CONLEY RICHARD K

    • Director
    		 0 2015-04-30 0

    FRENCH GREGORY M

    • Director
    		 0 2015-04-30 0

    ALIMI HOJABR CEO AND CHIEF SCIENCE OFFICER

    • Officer
    • Director
    		 125,000 2014-05-11 0

    HARISH SAMEER CHIEF FINANCIAL OFFICER

    • Officer
    		 74,600 2014-05-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HIGGINS MICHAEL J - Director

    		2016-02-25 12:54:48 -0500 2026-02-03 A 8,800 a 8,800 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PULMATRIX INC PULM 2023-11-28 22:15:04 UTC -4.3636 9.6836 100000
    PULMATRIX INC PULM 2023-11-28 21:45:03 UTC -4.3636 9.6836 100000
    PULMATRIX INC PULM 2023-11-28 21:15:04 UTC -4.3636 9.6836 100000
    PULMATRIX INC PULM 2023-11-28 20:45:04 UTC -4.3636 9.6836 100000
    PULMATRIX INC PULM 2023-11-28 20:15:04 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 19:45:03 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 19:15:04 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 18:45:03 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 18:15:03 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 17:45:04 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 17:15:04 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 16:45:04 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 16:15:04 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 15:45:03 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 15:15:03 UTC -4.3619 9.6819 100000
    PULMATRIX INC PULM 2023-11-28 14:45:04 UTC -4.3619 9.6819 95000
    PULMATRIX INC PULM 2023-11-28 14:15:04 UTC -4.3619 9.6819 95000
    PULMATRIX INC PULM 2023-11-28 13:45:04 UTC -4.6799 9.9999 90000
    PULMATRIX INC PULM 2023-11-28 13:15:03 UTC -4.6799 9.9999 90000
    PULMATRIX INC PULM 2023-11-28 12:45:04 UTC -4.6799 9.9999 90000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments